Prot#IMB-101-007: A Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients with Non-obstructive Hypertrophic Cardiomyopathy

Project: Research project

Project Details

StatusActive
Effective start/end date8/24/218/23/22

Funding

  • Cardiovascular Clinical Science Foundation (Prot#IMB-101-007)
  • Imbria Pharmaceuticals, Inc. (Prot#IMB-101-007)